AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L
Agricola
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L
American Journal of Clinical Nutrition, Vol. 88, No. 4, 1111-1118, October 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Intakes of long-chain n–3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis 1,2,3

Ka He, Kiang Liu, Martha L Daviglus, Elisabeth Mayer-Davis, Nancy Swords Jenny, Rui Jiang, Pamela Ouyang, Lyn M Steffen, David Siscovick, Colin Wu, R Graham Barr, Michael Tsai and Gregory L Burke

1 From the School of Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (KH and EM-D); the Feinberg School of Medicine, Northwestern University, Chicago, IL (KL and MLD); the University of Vermont College of Medicine, Colchester, VT (NSJ); the Columbia University Medical Center, New York, NY (RJ and RGB); the Johns Hopkins University School of Medicine, Baltimore, MD (PO); the School of Public Health, University of Minnesota, Minneapolis, MN (LMS and MT); the School of Medicine, University of Washington, Seattle, WA (DS); the National Heart, Lung, and Blood Institute, Bethesda, MD (CW); and the Wake Forest University of Health Sciences, Winston-Salem, NC (GLB)

2 Supported by grants no. N01-HC-95159, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, and HL077612 from the National Heart, Lung, and Blood Institute, National Institutes of Health.

3 Reprints not available. Address correspondence to K He, Departments of Nutrition and Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, 2202 McGavran-Greenberg Hall, CB# 7461, Chapel Hill, NC 27599. E-mail: kahe{at}unc.edu.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 PARTICIPANTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Data on the relations of different types of fish meals and long-chain n–3 polyunsaturated fatty acids (PUFAs) to measures of atherosclerosis are sparse.

Objective: We examined intakes of long-chain n–3 PUFAs and fish in relation to clinical measures of subclinical atherosclerosis.

Design: A cross-sectional study was conducted in a multiethnic group of 5488 adults aged 45–84 y and free of clinical cardiovascular disease. Diet was assessed by using self-administered food-frequency questionnaires. Subclinical atherosclerosis was determined by measurements of common carotid intima–media thickness (cCIMT, >80th percentile), internal CIMT (iCIMT, >80th percentile), coronary artery calcium score (CAC score, >0), or ankle-brachial index (ABI, <0.90).

Results: After adjustment for potential confounders, intakes of long-chain n–3 PUFAs and nonfried (broiled, steamed, baked, or raw) fish were inversely related to subclinical atherosclerosis determined by cCIMT but not by iCIMT, CAC score, or ABI. The multivariate odds ratio comparing the highest to the lowest quartile of dietary exposures in relation to subclinical atherosclerosis determined by cCIMT was 0.69 (95% CI: 0.55, 0.86; P for trend < 0.01) for n–3 PUFA intake; 0.80 (95% CI: 0.64, 1.01; P = 0.054) for nonfried fish consumption; and 0.90 (95% CI: 0.73, 1.11; P = 0.38) for fried fish consumption.

Conclusions: This study indicates that the dietary intake of long-chain n–3 PUFAs or nonfried fish is associated with a lower prevalence of subclinical atherosclerosis classified by cCIMT, although significant changes in iCIMT, CAC score, and ABI were not observed. Our findings also suggest that the association of fish and atherosclerosis may vary depending on the type of fish meal consumed and the measures of atherosclerosis.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
PARTICIPANTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Observational studies and randomized trials have indicated that higher intakes of long-chain (LC) n–3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and of fish are associated with a lower risk of cardiovascular disease (CVD) (1-4). Possible mechanisms underlying this cardioprotective effect include a reduction in serum triglycerides (5), a decrease in platelet aggregability (6), and the presence of antiarrhythmic effects (6). Whereas the hypotriglyceridemic effects of supplementation with high-dose LC n–3 PUFAs are well established (7), these fatty acids may also increase LDL cholesterol (8, 9) and enhance the oxidation of LDL cholesterol (10, 11). Indeed, previous studies did not provide a clear picture of the effects of LC n–3 PUFAs or fish on subclinical atherosclerosis. Data from both animal models (12-14) and humans (15-17) are inconsistent.

Computed tomography scanning of the coronary arteries for calcium is widely used as a noninvasive method of assessing early coronary artery disease. The presence of coronary artery calcium (CAC) is a predictor of a greater risk of future coronary events (18, 19). The ultrasonographic evaluation of the carotid intimal–medial thickness (CIMT) is also used to assess carotid atherosclerosis (20, 21). In addition, a low ankle-brachial index (ABI) has been reported to be associated with greater risks of death, total CVD, coronary heart disease, congestive heart failure, and symptomatic peripheral arterial disease (22-25). Although these measurements are widely employed as markers of subclinical atherosclerosis in various epidemiologic studies, few studies have used these measurements simultaneously in a single cohort.

To determine whether the previous inconsistent findings on fish and subclinical atherosclerosis can be partially explained by the different clinical measures used and to ascertain how different types of fish meals related to atherosclerosis, we examined fish consumption and LC n–3 PUFA intake in relation to clinical measures of atherosclerosis including common CIMT (cCIMT),internal CIMT (iCIMT), CAC score, and ABI in a multiethnic cohort of middle-aged and older men and women.


   PARTICIPANTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 PARTICIPANTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Study population
The Multi-Ethnic Study of Atherosclerosis (MESA) is a population-based study of 6814 men and women aged 45–84 y who are without clinical CVD and were recruited from 6 US communities. Participants were enrolled between August 1, 2000, and July 30, 2002. The self-identified ethnic background of the cohort is 38.5% white, 27.8% African American, 21.9% Hispanic, and 11.8% Chinese American. The primary goal of MESA is to determine the characteristics associated with subclinical CVD and its progression. Details of the sampling and recruitment procedures were published elsewhere (26). Participants completed a set of measurements of subclinical CVD and assessment of standard CVD risk factors, sociodemographic factors, diet, lifestyle, and psychosocial factors. In the present analysis, we excluded those who had missing data on diet (n = 577), ABI (n = 70), cCIMT (n = 74), iCIMT (n = 98), and who had extreme total energy intake (<600 or > 6000 kcal/d, n = 285). We also excluded participants without information on covariates used in the analysis (n = 222). After these exclusions, a total of 5488 participants remained in the analysis.

All participants provided informed consent. The MESA protocol was approved by institutional review boards at all participating sites.

Dietary assessment
Dietary information was assessed by using a self-administered food frequency questionnaire (FFQ) and dietary supplement form. The FFQ was based on an FFQ used in the multiethnic (non-Hispanic white, African American, and Hispanic) Insulin Resistance Atherosclerosis Study and was modified for the Diabetes Prevention Program to include foods typically consumed by a Chinese American population and to collect supplemental information (26, 27). Participants were asked to identify the usual frequency of consumption of the food items during the past year and the average serving size consumed. Nine frequency responses were available in the questionnaire, ranging from "never or rare" to ">2 times/d," and 3 serving sizes were specified: small, medium, and large. In the present study, fish consumption was defined as fish and other seafood intake. Participants were asked to indicate how often they consumed 1) fried fish or fish sandwich, fried shrimp, or calamari; 2) shrimp, lobster, crab, oysters, or mussels (not fried); 3) tuna, salmon, or sardines (including sashimi or sushi); and 4) other broiled, steamed, baked, or raw fish (eg, trout, sole, halibut, poke, or grouper).

Studies have suggested that the preparation method—in particular, frying—may substantially alter the fatty acid content of a fish meal (28) and that the associations with CVD risk may be different (29). In addition, the LC n–3 PUFA content in shellfish is relatively low. Therefore, we divided fish consumption into 3 groups: fried fish (including fried shellfish), nonfried fish (broiled, steamed, baked, or raw fish), and nonfried fish + shellfish. Because nearly 50% of participants reported no shellfish consumption, we were not able to analyze shellfish separately. The questionnaire also includes 3 questions related to mixed fish dishes such as the Chinese dishes of stir-fried shrimp or fish with vegetables or non-Chinese dishes such as pasta with seafood and seafood gumbo. Because we were not able to determine the exact portion of seafood in a mixed fish dish, we did not include mixed fish dishes in the main analyses. However, we included mixed fish dishes in the secondary analyses by assigning a weight 0.4, 0.5, or 0.6 for calculating the amount of fish in the mixed fish dishes. We converted fish consumption into servings per day and adjusted for serving size (ie, small = 0.5 x medium; medium = standard age- and sex-specific serving size; large = 1.5 x medium) (30). Nutrients including LC n–3 PUFAs were derived from the Minnesota Nutrition Data System NDS software (version 4.02/30; Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN) (31). Information on the dose of supplements including fish oil was acquired. The doses of supplements also were included in the estimation of nutrient intake.

Although the FFQ has not been validated in MESA, the Insulin Resistance Atherosclerosis Study questionnaire has shown reasonable validity and reliability in a diverse cohort (32). Compared with the average of eight 24-h recalls, the mean correlation coefficients of nutrient intake were 0.62 for non-Hispanic whites, 0.5 for African Americans, and 0.41 for Hispanics. The somewhat lower observed correlations among Hispanics were largely accounted for by differences in education across the ethnicities. For reliability, the mean correlation coefficient for nutrients evaluated was 0.62; it did not differ by ethnic subgroup.

Measures of subclinical atherosclerosis
In the present study, subclinical atherosclerosis was defined by CAC score, cCIMT, iCIMT, and ABI. The CAC score was measured by using 2 scans obtained on the same occasion in all participants during the clinical examination using electron beam computed tomography or multidetector computed tomography (33). The presence of CAC (Agatston score > 0) was considered as a marker of subclinical atherosclerosis.

Intimal-media thickness (IMT) was measured between the lumen-intima and media-adventitia interfaces of near and far walls of the common carotid artery (the 1-cm segment proximal to the bifurcation) and the internal carotid artery (including the bifurcation and 1 cm distal to the bifurcation) with B-mode ultrasound [Logiq 700 ultrasound machine; General Electric Medical Systems, Waukesha, WI] (34). Subclinical atherosclerosis was defined by the values of cCIMT or the iCIMT index of >80th percentile values.

All participants were evaluated in the supine position after ≥5 min of rest. Systolic blood pressure was measured in arms and in the right and left posterior tibial and dorsalis pedis artery. The resting ABI was determined for each leg by dividing the systolic blood pressure at the ankle by the brachial pressure; the lower of the ABI values obtained in each leg was used in the data analysis (35). An ABI value < 0.9 was classified as subclinical atherosclerosis in this analysis.

Assessment of other covariates
Demographic and major lifestyle variables were collected via questionnaire; they included age, sex, race-ethnicity, education level, household income, smoking status, medical conditions, and current medication use. Body weight and height were directly measured according to standard procedures. Body mass index (BMI; in kg/m2) was calculated. Physical activity was measured by using a detailed, semiquantitative questionnaire adopted from the Cross-Culture Activity Participation Study (26). Total physical activity was computed as the total intentional exercise [all light, moderate, and vigorous activities (min/wk)] multiplied by the activities' individual metabolic equivalent values.

Statistical analysis
Quartiles of fish consumption and LC n–3 PUFA intake were created and used in the analysis. Age-, sex-, and race-adjusted means and SEs or proportions were computed for selected variables by quartiles of LC n–3 PUFA intake. Logistic regression analyses were used to examine the associations of fish consumption and LC n–3 PUFA intake with subclinical atherosclerosis, which are classified by cCIMT (>80th percentile), iCIMT (>80th percentile), CAC (Agatston score > 0), or ABI (<0.90). We considered a number of potential confounders in the multivariable models, including age, race-ethnicity, sex, BMI, physical activity, household income, smoking status, systolic blood pressure, antihypertensive medication use, and several dietary variables. We first ran a basic model by including a few demographic variables. Other major lifestyle factors and dietary variables were included in the analysis as potential confounders based on previous studies and statistical tests. Covariates were added to the basic regression model in a hierarchical fashion so that we can assess the effect of adjustment for specific confounders on the association of each combination of dietary exposure and clinical measures of atherosclerosis. In addition, we adjusted for fried fish when examining nonfried fish and vice versa. Test for trends across quartiles was evaluated by using the median values of each quartile of fish and LC n–3 PUFA intake. In a sensitivity analysis, different cutoffs (ie, 10, 50, 100, or 200) were used for CAC score to determine whether the results for fish or LC n–3 PUFAs and CAC score were robust. All P values were 2-sided, and P < 0.05 was considered statistically significant. SAS software (version 9; SAS Institute Inc, Cary, NC) was used for all analyses.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 PARTICIPANTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Age-, sex-, and race- adjusted characteristics of the study population according to dietary intake of LC n–3 PUFA are shown in Table 1Go. The median daily intakes of LC n–3 PUFA across quartiles were 40, 80, 120, and 220 mg, respectively. Compared with participants in the lowest quartile of LC n–3 PUFA intake, those in the highest quartile were more likely to have higher education and household income; they also exercised more and were less likely to be current smokers. Moreover, participants in the highest quartile of LC n–3 PUFA intake had lower intakes of alcohol, total energy, saturated fat, and trans fat and a higher intake of {alpha}-linolenic acid.


View this table:
[in this window]
[in a new window]

  		TABLE 1 Age-, sex-, and race-adjusted characteristics of the study population by quartile (Q) of long-chain (LC) n–3 polyunsaturated fatty acid (PUFA) intake—MESA baseline examination, 2000–20021

 
In multivariate analysis, a significant inverse association was observed between LC n–3 PUFA intake and subclinical atherosclerosis as determined by cCIMT. The odds of having cCIMT > 80th percentile was 31% lower [odds ratio (OR): 0.69; 95% CI: 0.55, 0.86; P for trend = 0.005] for participants in the highest quartile of LC n–3 PUFA intake than for those in the lowest quartile (Table 2Go). Greater nonfried fish consumption was related to lower odds of cCIMT > 80th percentile (OR: 0.80; 95% CI: 0.64, 1.01; P for trend = 0.054), but this inverse association was attenuated by including shellfish (OR: 0.84; 95% CI: 0.67, 1.04; P for trend = 0.15). Fried fish was not related to cCIMT. In addition, no inverse associations were observed for LC n–3 PUFA, nonfried fish, nonfried fish + shellfish, or fried fish intake and subclinical atherosclerosis classified by iCIMT, CAC score, or ABI (Table 2Go).


View this table:
[in this window]
[in a new window]

  		TABLE 2 Multivariate-adjusted odds ratios (ORs) (and 95% CIs) of subclinical atherosclerosis determined by various biomarkers by quartile (Q) of dietary intake of fish and long-chain (LC) n–3 polyunsaturated fatty acids (PUFAs)—MESA, 2000–20021

 
After adjustment for potential confounders, LC n–3 PUFA intake and fish consumption were significantly inversely related to blood triglyceride concentrations. In addition, intakes of LC n–3 PUFAs and nonfried fish were positively associated with blood HDL-cholesterol concentrations. The ratio of total to HDL cholesterol (total:HDL cholesterol) has been suggested as a powerful predictor of coronary heart disease (36). In the present study, dietary LC n–3 PUFA intake (but not fish consumption) was significantly inversely related to total:HDL cholesterol (Table 3Go).


View this table:
[in this window]
[in a new window]

  		TABLE 3 Blood lipid profile by quartile (Q) of dietary intakes of fish and long-chain (LC) n–3 polyunsaturated fatty acid (PUFA)—MESA, 2000–20021

 
By stratifying data, we found that the inverse associations between nonfried fish consumption or LC n–3 PUFA intake and cCIMT were not appreciably modified by sex. The P values for the sex x LC n–3 PUFA and sex x nonfried fish interactions were 0.95 and 0.57, respectively. In addition, the observed inverse associations remained in whites but not other races-ethnicities (data not shown).

In sensitivity analyses (data not shown), we used different cutoffs (ie, 10, 50, 100, or 200) for CAC score, but the results were not materially altered. In addition, {approx}4% of participants used fish-oil supplements. The results remained when we excluded the supplement users in the analyses. In the present study, we were not able to analyze shellfish separately because nearly half of the participants reported no shellfish consumption. Nevertheless, no association with any of the clinical markers was observed by dichotomizing shellfish consumption. Moreover, we included mixed fish dishes in the analysis by assigning a weight of 0.4, 0.5, or 0.6, respectively, to mixed fish dishes. The observed inverse associations were slightly attenuated.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 PARTICIPANTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
In this cross-sectional study, we found that dietary intake of LC n–3 PUFAs and nonfried fish consumption were associated with a lower OR of subclinical atherosclerosis classified by cCIMT but not iCIMT, CAC score, or ABI. The inverse associations were consistent in men and in women.

Despite potential benefits of dietary LC n–3 PUFAs in the reduction of coronary heart disease mortality (3), it is not clear whether LC n–3 PUFAs have a direct effect on the pathogenesis of atherosclerosis. A randomized controlled trial among 59 patients with angiographically documented coronary heart disease showed that fish-oil treatment (6 g/d of EPA and DHA) for 2 y had no major favorable effect on the diameter of atherosclerotic coronary arteries (15). Another randomized, double-blind, placebo-controlled trial in 223 patients with angiographically proven coronary artery disease found that a fish-oil intake of {approx}1.65 g/d of EPA and DHA for 2 y modestly mitigated the course of human coronary atherosclerosis (16) but had no effect on progression of carotid atherosclerosis (37). A change in the extent of atherosclerosis in carotid arteries and in coronary arteries in these patients during the same period was not correlated (37). The association of fish or LC n–3 PUFA with atherosclerosis was also examined in observational studies. A cross-sectional study conducted in 470 Japanese found that serum LC n–3 PUFA concentrations were inversely related to the probability of common carotid plaques (38). In addition, a prospective cohort study of postmenopausal women with coronary artery disease (n = 229) found that fish consumption was associated with significantly less progression of coronary atherosclerosis (17).

The effects of LC n–3 PUFAs on atherosclerosis may be mediated through PUFAs' roles in lipoprotein metabolism. In the present study, we found that fish and LC n–3 PUFA intakes were associated with lower triglyceride concentrations. LC n–3 PUFAs and nonfried fish were positively related to HDL. LC n–3 PUFAs also were inversely associated with total:HDL cholesterol. No statistically significant associations were found for LDL and total cholesterol. A recent meta-analysis of 21 randomized controlled trials summarized the effects of fish-oil supplementation on lipid values (39). The meta-analysis suggests that fish-oil consumption significantly reduces serum triglycerides and modestly improves HDL. However, fish-oil intake increases the concentration of LDL cholesterol and has no effect on total cholesterol. It is uncertain how these combined effects of LC n–3 PUFAs on lipid values affect the development or progression of atherosclerosis. In addition, LC n–3 PUFAs may have an antiplatelet aggregation effect (40, 41) and a modest hypotensive effect (42). Moreover, studies indicate that LC n–3 PUFAs have anti-inflammatory effects and may improve endothelial function (43, 44). The associations of LC n–3 PUFAs with atherosclerosis may reflect the integrative effects of LC n–3 PUFAs with lipids, thrombosis, inflammation, and endothelial function.

A major strength of the present study is that we had multiple clinical measures of subclinical atherosclerosis. However, in the present study, we observed only an inverse association between LC n–3 PUFAs and cCIMT. Although all of these measurements are recognized as markers of subclinical atherosclerosis, they may be different surrogates of the atherosclerotic process. For example, ABI is generally thought of as the best clinical marker of diffuse atherosclerosis, the CAC score may reflect atherosclerosis in coronary arteries, and cCIMT and iCIMT are considered to be markers of carotid atherosclerosis. We found that dietary LC n–3 PUFAs were associated with cCIMT but not iCIMT. One possible explanation is that iCIMT mainly reflects hypertension status but not carotid atherosclerosis per se. Of note, intakes of LC n–3 PUFAs and fish were relatively low in the current cohort. The observed null associations in the present study may be partially explained by the low LC n–3 PUFA intake or fish consumption. Nevertheless, significant risk reduction of ischemic stroke with similar amounts of LC n–3 PUFA intake was reported (45). In addition, we examined the associations among multiple ethnic groups. Although qualitatively similar associations were observed across ethnicities, the statistically significant inverse associations between LC n–3 PUFAs and cCIMT remained only in whites. Notably, whites make up the largest racial-ethnic group in MESA. The relatively small numbers of participant identified as having cCIMT > 80th percentile in other races-ethnicities, especially Chinese Americans and Hispanics, may limit our ability to observe any possible significant association. Another strength of this study is that we separately examined the consumption of fried fish, nonfried fish, and nonfried fish + shellfish in relation to measures of atherosclerosis. Shellfish contain relatively low concentrations of LC n–3 PUFAs. In the present study, the observed inverse association between nonfried fish and cCIMT was attenuated by the inclusion of shellfish. Although it was modestly inversely related to blood triglyceride concentrations, we found no beneficial effects of fried fish consumption on atherosclerosis. Our findings are biologically plausible, because frying may affect a fish meal's fatty acid composition (28), at least partly by reducing LC n–3 PUFA content and producing trans unsaturated fatty acids. These changes in fatty acid profile of cooked fish meals may somewhat attenuate or cancel the potential benefit of fish consumption.

The present study had some limitations. First, given the cross-sectional analysis, the possibility of reverse causation cannot be completely excluded. In addition, we could not account for the effects of changes in diet on atherosclerosis. For example, some participants who were at high risk of CVD may have changed their diet (eg, increased fish consumption or started taking a fish-oil supplement) on the advice of physicians or due to information from media sources. This diet change could dilute any inverse association of LC n–3 PUFAs or fish and subclinical atherosclerosis. Second, because dietary intake was self-reported in the present study, the inevitable measurement errors in estimating fish consumption as well as LC n–3 PUFA intake could bias our results. Third, although we adjusted for a number of potential confounders in the analysis, residual confounding and possible confounding from unmeasured dietary and nondietary factors could not be ruled out. For example, information on mercury and other contaminants in fish was not available. A study has suggested that mercury may increase the risk of myocardial infarction (46). Thus, mercury in fish may confound our findings. Fourth, nearly 20% participants were excluded in the analyses, mainly because of missing data. Although the characteristics of these 2 groups did not differ significantly, the results may be affected by the exclusions. Finally, the relatively small numbers of participant with ABI < 0.90 may limit our capability to examine the associations by using the ABI as the measure of subclinical atherosclerosis.

In summary, the present study indicates that dietary intakes of LC n–3 PUFAs and nonfried fish are inversely associated with subclinical atherosclerosis determined by cCIMT but not iCIMT, CAC score, or ABI. Our findings also suggest that results of clinical and epidemiologic research may differ according to the measures used to assess atherosclerosis and the type of fish meal consumed.


   ACKNOWLEDGMENTS
 
We thank the other investigators and the staff of the Multi-Ethnic Study of Atherosclerosis (MESA) for their valuable contributions. A full list of participating investigators and institutions can be found at http://www.mesa-nhlbi.org. We also thank Laura Colangelo for her assistance in statistic analyses and SAS programming.

The authors' responsibilities were as follows—KH: designed the study, conducted the analyses, and drafted the manuscript; KL: provided statistical advice and helped revise the manuscript; and MLD, EMD, NSJ, RJ, PO, LMS, DS, CW, RGB, MT, and GLB critically revised the manuscript for important intellectual content. None of the authors had a personal or financial conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 PARTICIPANTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Dietary supplementation with n–3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447–55.[Medline]
  2. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–57.[Medline]
  3. He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004;109:2705–11.[Medline]
  4. Bucher HC, Hengstler P, Schindler C, Meier G. n–3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298–304.[Medline]
  5. Roche HM, Gibney MJ. Effect of long-chain n–3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000;71(suppl):232S–7S.[Abstract/Free Full Text]
  6. Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr 2000;71(suppl):202S–7S.[Abstract/Free Full Text]
  7. Harris WS. N–3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(suppl):1645S–54S.
  8. Reis GJ, Silverman DI, Boucher TM, et al. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am J Cardiol 1990;66:1171–5.[Medline]
  9. Fumeron F, Brigant L, Ollivier V, et al. n–3 Polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. Am J Clin Nutr 1991;54:118–22.[Abstract/Free Full Text]
  10. Harats D, Dabach Y, Hollander G, et al. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 1991;90:127–39.[Medline]
  11. Whitman SC, Fish JR, Rand ML, Rogers KA. n–3 Fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo. Arterioscler Thromb 1994;14:1170–6.[Abstract/Free Full Text]
  12. Harker LA, Kelly AB, Hanson SR, et al. Interruption of vascular thrombus formation and vascular lesion formation by dietary n–3 fatty acids in fish oil in nonhuman primates. Circulation 1993;87:1017–29.[Medline]
  13. Rich S, Miller JF Jr, Charous S, et al. Development of atherosclerosis in genetically hyperlipidemic rabbits during chronic fish-oil ingestion. Arteriosclerosis 1989;9:189–94.[Abstract/Free Full Text]
  14. Fincham JE, Gouws E, Woodroof CW, et al. Atherosclerosis. Chronic effects of fish oil and a therapeutic diet in nonhuman primates. Arterioscler Thromb 1991;11:719–32.[Abstract/Free Full Text]
  15. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995;25:1492–8.[Abstract]
  16. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999;130:554–62.[Abstract/Free Full Text]
  17. Erkkila AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004;80:626–32.[Abstract/Free Full Text]
  18. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003;228:826–33.[Abstract/Free Full Text]
  19. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210–5.[Abstract/Free Full Text]
  20. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089–94.[Medline]
  21. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87:II56-65.[Medline]
  22. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991;87:119–28.[Medline]
  23. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999;19:538–45.[Abstract/Free Full Text]
  24. Jager A, Kostense PJ, Ruhe HG, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:617–24.[Abstract/Free Full Text]
  25. McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 1999;133:33–40.[Medline]
  26. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871–81.[Abstract/Free Full Text]
  27. Mayer-Davis EJ, Sparks KC, Hirst K, et al. Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. Ann Epidemiol 2004;14:763–72.[Medline]
  28. Candela M, Astiasaran I, Bello J. Deep-fat frying modifies high-fat fish lipid fraction. J Agric Food Chem 1998;46:2793–6.
  29. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003;107:1372–7.[Medline]
  30. Cummings SR, Block G, McHenry K, Baron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol 1987;126:796–802.[Abstract/Free Full Text]
  31. Minnesota Nutrition Coordinating Center. Minnesota Nutrition Data System (NDS). Version 4.02; Nutrient Database Version 30. Minneapolis, MN: Nutrition Coordinating Center, University of Minnesota, 1999.
  32. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, et al. Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol 1999;9:314–24.[Medline]
  33. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35–43.[Abstract/Free Full Text]
  34. O'Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22:1155–63.[Abstract/Free Full Text]
  35. Vogt MT, McKenna M, Wolfson SK, Kuller LH. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis 1993;101:191–202.[Medline]
  36. Shai I, Rimm EB, Hankinson SE, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004;110:2824–30.[Medline]
  37. Angerer P, Kothny W, Stork S, von Schacky C. Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002;54:183–90.[Abstract/Free Full Text]
  38. Yamada T, Strong JP, Ishii T, et al. Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis 2000;153:469–81.[Medline]
  39. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006;189:19–30.[Medline]
  40. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978;2:117–9.[Medline]
  41. Agren JJ, Vaisanen S, Hanninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1997;57:419–21.[Medline]
  42. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523–33.[Medline]
  43. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n–3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806–11.[Abstract/Free Full Text]
  44. Niu K, Hozawa A, Kuriyama S, et al. Dietary long-chain n–3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006;84:223–9.[Abstract/Free Full Text]
  45. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA 2002;288:3130–6.[Abstract/Free Full Text]
  46. Guallar E, Sanz-Gallardo MI, van't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002;347:1747–54.[Abstract/Free Full Text]
Received for publication November 27, 2007. Accepted for publication June 17, 2008.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L
Agricola
Right arrow Articles by He, K.
Right arrow Articles by Burke, G. L

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS